Extension Study of V72P13 to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered as a Booster or as a Two-dose Catch-up to Healthy Toddlers
Clinical trial NCT00847145 · COMPLETED
Trial details
- NCT number
- NCT00847145
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2010-08-01
- Enrollment
- 2249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.